Joseph Douglas Lyon - 03 Aug 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Accounting & Technology Officer
Issuer ticker: CORT
Reported as of: 03 Aug 2026
Net transaction value: -$175,806
SEC form: 4
Accepted by SEC: 05 Aug 2026, 17:48:38 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon

Key filing fact

Joseph Douglas Lyon filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 05 Aug 2026.

Key facts

This page summarizes Joseph Douglas Lyon's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2026, 17:48.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$175,806.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001817838 Primary reporting owner

Lyon Joseph Douglas

Relationship: Chief Accounting & Technology Officer
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon
Signature date: 05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Sale

Transaction value: $175,806
Shares: -1,540
Change %: -22%
Price: $114.16
Shares after: 5,495
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

SEC remarks

Chief Accounting & Technology Officer